Economic evaluation of margetuximab vs. trastuzumab for pretreated ERBB2-positive advanced breast cancer in the US and China

• Main Authors: Zhiyuan Tang (Author), Xin Xu (Author), Jie Gao (Author), Ling Chen (Author), Qiuyan Zhu (Author), Jinli Wang (Author), Xiaoyu Yan (Author), Bohua Chen (Author), Yumei Zhu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ObjectiveTo assess the economic evaluation of margetuximab plus chemotherapy over trastuzumab plus chemotherapy for women with pretreated ERBB2-positive advanced breast cancer in the United States (US) and China.MethodsBased on the SOPHIA trial, a three-state Markov model was developed to compare th...